Unite De Recherche Clinique HIA Begin

At Unite De Recherche Clinique HIA Begin in Saint-Mande, clinical studies in oncology and digestive system diseases focus on major cancers such as colon carcinoma and advanced prostate cancer. The research is centered on evaluating new treatment strategies and improving outcomes for patients with difficult-to-treat malignancies.

• Testing whether newer cancer treatment combinations can improve disease control in metastatic prostate cancer
• Studying treatment effectiveness in colorectal cancer after surgery and standard therapy
• Exploring better ways to guide care for patients with high-risk digestive tract cancers

These trials reflect a strong clinical focus on improving survival, refining treatment selection, and supporting more personalized cancer care.

Research in male urogenital diseases includes studies for adenocarcinoma of the prostate, with attention to men who are frail or have advanced disease. The goal is to assess whether adding new therapies can offer better disease control than standard approaches alone.

• Evaluating new options for castration-naïve metastatic prostate cancer
• Comparing treatment effectiveness in patients not receiving other intensive cancer therapies
• Seeking improved protection against progression in advanced prostate cancer

This area highlights the site’s interest in testing more effective and better-tolerated approaches for men living with advanced prostate cancer.

The site also conducts studies in digestive system cancers, especially colon carcinoma, using circulating tumor DNA as a tool to help guide treatment decisions. These trials aim to improve how clinicians identify patients who may benefit from additional therapy after surgery.

• Using ctDNA to better identify recurrence risk in colorectal cancer
• Evaluating whether treatment can extend time before disease returns
• Improving post-surgery cancer care through more precise monitoring

This research combines cancer treatment with diagnostic refinement, supporting more individualized management for patients with high-risk colorectal cancer.

In skin and connective tissue diseases, the clinical research includes hidradenitis suppurativa, a chronic inflammatory condition that can significantly affect quality of life. The studies are designed to test whether new therapies can reduce symptoms and improve patient outcomes.

• Assessing a new treatment for hidradenitis suppurativa
• Measuring improvement in disease signs and symptom control
• Exploring more effective options for a long-term inflammatory skin disorder

These trials show that the site’s portfolio extends beyond cancer, with research aimed at better treatment choices for challenging chronic skin disease.

Another important research theme at Unite De Recherche Clinique HIA Begin is thromboprophylaxis for patients with advanced germ cell tumors. The studies look at how best to prevent venous thromboembolic events during cancer treatment, especially in patients with added risk factors.

• Preventing blood clots in patients receiving treatment for metastatic germ cell cancer
• Evaluating supportive care strategies during chemotherapy
• Reducing treatment-related complications in patients with elevated clotting risk

This line of research supports safer cancer therapy by focusing on complication prevention alongside disease treatment.